Inflammatory Arthritis Research Consortium 2025 Round 2

Consortium funding should seek to gain distinct progress in one or more of the areas specifically in relation to inflammatory arthritis: 

• Managing people's risk factors, prediction of disease occurrence and enabling earlier detection and diagnosis. 
• Provision of personalised and effective treatment interventions that give confidence in expectation of treatment responses and disease progression, particularly in relation to optimising therapy in early disease. 
• Managing prediction, prognosis and treatment of refractory disease. 
• Understanding and predicting the long-term outcomes of disease and treatment. 

- PI must be from a UK institution

- International members with unique expertise are welcome

Funding: £3,000,000 total 

Duration: 2 years 

Research Authority due date: 23.4.25

Intent to submit (required) due date: 30.4.25

Full proposal due date: 25.6.25